Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 10, 2021

SELL
N/A
-10,400 Closed
0 $0
Q2 2021

Aug 04, 2021

SELL
N/A
-10,650 Reduced 50.59%
10,400 $101,000
Q1 2021

Apr 30, 2021

SELL
N/A
-24,758 Reduced 54.05%
21,050 $226,000
Q4 2020

Jan 29, 2021

BUY
N/A
27,212 Added 146.33%
45,808 $674,000
Q3 2020

Nov 05, 2020

BUY
N/A
6,371 Added 52.11%
18,596 $264,000
Q2 2020

Jul 23, 2020

BUY
N/A
12,225 New
12,225 $99,000
Q4 2018

Feb 01, 2019

SELL
N/A
-29,300 Closed
0 $0
Q3 2018

Oct 25, 2018

SELL
N/A
-100 Reduced 0.34%
29,300 $170,000
Q2 2018

Jul 20, 2018

BUY
N/A
1,000 Added 3.52%
29,400 $176,000
Q1 2018

Apr 18, 2018

BUY
N/A
2,000 Added 7.58%
28,400 $204,000
Q3 2017

Oct 17, 2017

BUY
N/A
26,400
26,400 $136,000

About Trillium Therapeutics Inc.


  • Ticker TRIL
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 104,995,000
  • Market Cap $1.94B
More about TRIL
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.